NCT00379639 - A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2006

Primary Completion Date

July 1, 2008

Study Completion Date

July 1, 2008

Conditions

Pancreatic Cancer

Interventions

DRUG

Romidepsin

7, 10 or 12 mg/m\^2 via intravenous infusion over 4 hours on either Days 1, 8 and 15 or Days 1 and 15 of each 28-day cycle.

DRUG

Gemcitabine

800 or 1000 mg/m\^2 via intravenous infusion over 30 minutes on either Days 1,8 and 15 or Days 1 and 15 of each 28 day cycle.

Trial Locations (1)

Sarah Cannon Research Institute, Nashville